What is ARLO's health score?

Arlo Technologies, Inc. (ARLO) has a TradeApes health score of 61 out of 100, rated Healthy. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is ARLO's estimated fair value?

Based on our 5-year discounted cash flow model, Arlo Technologies, Inc.'s estimated fair value is $10.85 per share, representing a -16.8% downside from the current price. This is a model estimate, not a price target or investment recommendation.

Is ARLO undervalued or overvalued?

Our model currently rates ARLO as Fair Value. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for ARLO... Refresh in a moment for the full analysis.

Arlo Technologies, Inc. (ARLO)

Technology Fair Value low healthy

$13.04

Updated: 2026-06-05

TradeApes Score

Financial Strength

75 Strong

Operating Trend

68 Healthy

Relative Value

55 Mixed

Capital Allocation

20 Stressed

Risk

80 Strong

Est. Fair Value $10.85

DCF Upside -16.8%

Sector Rank #367 of 7742

Key Findings

+ Historically cheap — EV/EBITDA in bottom 25% of its 5-year range

Unlock Full Report →

− Extreme P/E — above 45×, very high expectations embedded in price

Unlock Full Report →

3 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.